Pulmonary disorders present significant challenges in healthcare, necessitating the
development of innovative therapeutic approaches. Nanomedicine has emerged as a …

This study focuses on the innovation of an inhaled sustained release form of insulin and the
development of a neuro-fuzzy model specifically tailored to predict insulin release kinetics …

The successful development of several unique and intelligent drug delivery systems,
characterized by enhanced therapeutic effectiveness and improved patient compliance …

The diffusion coefficients of poly (ethylene glycol) methyl ether thiol (PEGSH)-functionalized
gold nanoparticles (NPs) with different effective grafting densities were measured in …

Ticagrelor is a BCS class IV drug that inhibits platelet action by reversibly binding to the
P2Y12 receptor. One of the major challenges faced by the class IV (low solubility, low …

Globally, allergic airway diseases caused immense threats with increased mortality rates.
Current pharmacological agents have resulted in poor patient survival due to decreased …

Cancer is currently the leading cause of mortality. There are a variety of medicines available
to treat cancer, but none has been shown to be fully safe and effective. The toxicity of …

Biobased nanomaterials have emerged as a pivotal element in modern drug delivery,
garnering substantial attention within scientific research. These materials, sourced from …

The pulmonary delivery of antibiotics is a pivotal approach in treating respiratory infections,
enabling targeted drug administration while minimizing systemic side effects. In recent …

The successful creation of several unique and intelligent drug delivery systems with
improved therapeutic effectiveness, improved patient compliance, and new developments …